SCHEMBL30833690

SCHEMBL30833690

Cc1nn(C2CCN(C)CC2)c2ccc(N)cc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ALOX15 P16050 1/20 0.44
HTR1D P28221 1/20 0.42
HTR1B P28222 1/20 0.42
GRM4 Q14833 1/20 0.40
PDE7A Q13946 5/20 0.37
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 1/20 0.36
GFER P55789 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HPGD P15428 1/20 0.35
P2RX7 Q99572 1/20 0.34
CFTR P13569 1/20 0.34
BRPF1 P55201 1/20 0.33
RAD52 P43351 1/20 0.33
ADRA1A P35348 1/20 0.33
HRH1 P35367 1/20 0.33
ADRA1B P35368 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29190627 1.00 GAA (0.49) GAASMN1; SMN2ALOX15HTR1DHTR1B
SCHEMBL14909872 0.90 GRM4 (0.43) GAASMN1; SMN2HTR1DHTR1BGRM4
SCHEMBL31251289 0.90 GRM4 (0.43) GAASMN1; SMN2HTR1DHTR1BGRM4
SCHEMBL13135674 0.80 SMN1; SMN2 (0.46) GAASMN1; SMN2ALOX15HTR1DHTR1B
SCHEMBL29190685 0.78 MAPT (0.45) GAASMN1; SMN2MAPTALDH1A1
SCHEMBL30833689 0.78 MAPT (0.45) GAASMN1; SMN2MAPTALDH1A1
SCHEMBL25337095 0.75 GAA (0.42) GAASMN1; SMN2ALOX15PDE7AP2RX7
SCHEMBL3358219 0.73 HTR1D (0.43) GAASMN1; SMN2ALOX15HTR1DHTR1B
SCHEMBL3358945 0.73 ALOX15 (0.52) GAASMN1; SMN2ALOX15HTR1DHTR1B
SCHEMBL21198529 0.72 GAA (0.47) GAAGRM4PDE7AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113896744-B Selective EGFR inhibitor 成都先导药物开发股份有限公司 2024-04-16 CN disclosed